Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun:1224:114122.
doi: 10.1016/j.comptc.2023.114122. Epub 2023 Apr 6.

Stereoselective glycosylation reactions with 2-deoxyglucose: a computational study of some catalysts

Affiliations

Stereoselective glycosylation reactions with 2-deoxyglucose: a computational study of some catalysts

Spencer Haisha et al. Comput Theor Chem. 2023 Jun.

Abstract

2-Deoxy glycosides are important components of many oligosaccharides with antibiotic and anti-cancer activity, but their synthesis can be very challenging. Phenanthrolines and substituted pyridines promote stereoselective glycosylation of 1-bromo sugars via a double SN2 mechanism. Pyridine reacting with α-bromo, 2-deoxyglucose was chosen to model this reaction. The first step involves displacement of bromide by pyridine which can be rate limiting because bromide ion is poorly solvated in the non-polar solvents used for these reactions. We examined a series of small molecules to bind bromide and stabilize this transition state. Geometry optimization and vibrational frequencies were calculated using M06-2X/6-31+G(d,p) and SMD implicit solvation for diethyl ether. More accurate energies were obtained with M06-2X/aug-cc-pVTZ and implicit solvation. Urea, thiourea, guanidine and cyanoguanidine bind bromide more strongly than alkylamines, (NH2CH2CH2)nNH3-n. Compared to the uncatalyzed reaction, urea, thiourea and cyanoguanidine lower the free energy of the transition state by 3 kcal/mol while guanidine lowers the barrier by 2 kcal/mol.

Keywords: 2-deoxyglucose; DFT; catalysis; glycosylation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement The authors declare that they have no known conflict of interests that could have appeared to influence the work reported in this paper. Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.
Complexes of Br with (a) 1,2-diaminoethane, (b) bis(2-aminoethyl)amine and (c) tris(2-aminoethyl)amine (H-Br distances in Å).
Figure 2.
Figure 2.
Complexes of Br with (a) urea, (b) thiourea, (c) guanidine and (d) cyanoguanidine (H-Br distances in Å).
Figure 3.
Figure 3.
Transition structures for the SN2 reaction of pyridine 1-bromo, 2-deoxyglucose catalyzed by (a) urea, (b) thiourea, (c) guanidine and (d) cyanoguanidine (distances in Å). For the uncatalyzed reaction R(C1-N) = 2.163 Å and R(C1-Br) = 2.815 Å.
Figure 4.
Figure 4.
Post-transition state minima for pyridine displacing Br in 1-bromo, 2-deoxyglucose complexed with (a) urea, (b) thiourea, (c) guanidine and (d) cyanoguanidine (H-Br distances in Å)
Figure 5.
Figure 5.
Enthalpy profile for the reaction with and without the catalyzing ligands.
Figure 6.
Figure 6.
Free energy profile for the reaction with and without the catalyzing ligands.
Scheme 1.
Scheme 1.
Glycosylation reactions to form α- and β-2-deoxy glycosides.
Scheme 2.
Scheme 2.
First step in the glycosylation of α-bromo, 2-deoxyglucose catalyzed by pyridine. The glycosylation is completed in a second SN2 reaction, in which the ROH nucleophile displaces the pyridine.

Similar articles

References

    1. Elshahawi SI, Shaaban KA, Kharel MK, Thorson JS, A comprehensive review of glycosylated bacterial natural products, Chem. Soc. Rev, 44 (2015) 7591–7697. - PMC - PubMed
    1. Nicolaou KC, Li YW, Sugita K, Monenschein H, Guntupalli P, Mitchell HJ, Fylaktakidou KC, Vourloumis D, Giannakakou P, O’Brate A, Total synthesis of apoptolidin: Completion of the synthesis and analogue synthesis and evaluation, J. Am. Chem. Soc, 125 (2003) 15443–15454. - PubMed
    1. Langenhan JM, Peters NR, Guzei IA, Hoffmann M, Thorson JS, Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization, Proc. Natl. Acad. Sci. USA, 102 (2005) 12305–12310. - PMC - PubMed
    1. Iyer AKV, Zhou MQ, Azad N, Elbaz H, Wang L, Rogalsky DK, Rojanasakul Y, O’Doherty GA, Langenhan JM, A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides, ACS Med. Chem. Lett, 1 (2010) 326–330. - PMC - PubMed
    1. Zhu XM, Schmidt RR, New Principles for Glycoside-Bond Formation, Angew. Chem. Int. Ed. Engl, 48 (2009) 1900–1934. - PubMed

LinkOut - more resources